This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2022, 18, 916–925, doi:10.3762/bjoc.18.91
Graphical Abstract
Figure 1: Chemical structures of compounds 1–8.
Figure 2: ORTEP drawing of 2 (displacement ellipsoids are drawn at the 50% probability level).
Figure 3: Experimental and calculated ECD curves of (+)-1.
Figure 4: 1H-1H COSY, key HMBC correlations, and NOESY correlations of compound 5.
Figure 5: Experimental ECD curves of compounds (+)-4, (−)-4 (top), (+)-5, and (−)-5 (bottom).
Scheme 1: Proposed cyclization pathway of terpene intermediates and plausible post-modifications of compounds ...
Figure 6: Compound 3 reduced the mRNA levels of TNF-α (left) and CCL2 (right) in LPS-stimulated RAW264.7 macr...
Beilstein J. Org. Chem. 2019, 15, 2380–2389, doi:10.3762/bjoc.15.230
Scheme 1: The structure (A) of reporter Glyco-DTE and working principle (B) of photochromic glycosheet Glyco-...
Scheme 2: Synthetic route to dithienylethene fluorescence reporters Glyco-DTE and 8o. VcNa: sodium ascorbate.
Figure 1: Absorption spectral changes (A), absorption fatigue resistance (B), emission spectral changes (C) a...
Figure 2: (A) The absorbance spectrum and (B) high resolution TEM image of 2D MnO2 nanosheets (1 × 10−5 g/mL)...
Figure 3: (A) Emission spectral changes of reporter Glyco-DTE (1 × 10−5 mol/L in PBS buffer, 0.25‰ Triton X-1...
Figure 4: (A) Fluorescence imaging of HepG2 cells and HeLa cells after incubated with reporters Glyco-DTE (20...
Figure 5: (A) Fluorescence imaging of HepG2 cells and HeLa cells after incubated with Glyco-DTE@MnO2 photochr...
Beilstein J. Org. Chem. 2013, 9, 1551–1558, doi:10.3762/bjoc.9.176
Figure 1: The 2-methyl-4(1H)-quinolone compounds: aurachins and endochin.
Scheme 1: Synthesis of aurachin D (4) and geranyl (9), prenyl (10) and methyl (11) analogues.
Scheme 2: Strategy toward the heterocyclic core of aurachin H.
Figure 2: (A) Loss of mitochondrial membrane potential in human U-2 OS osteosarcoma cells that were treated w...